Background: Data regarding the minimum duration of intrapartum antibiotic prophylaxis
(IAP) required for preventing group B Streptococcus (GBS) early-onset sepsis are conflicting …

Objectives: To determine the prevalence of maternal colonization with group B
streptococcus (GBS), and early onset GBS disease (EOGBSD) after implementation of …

Group B streptococcus (GBS) is the leading bacterial infection associated with morbidity and
mortality of newborns in the United States. Most neonatal infections can be prevented …

Group B streptococcus (GBS) is a leading cause of serious neonatal infections. Maternal
GBS colonization is associated with early-and late-onset neonatal disease (EOD/LOD). In …

Objective To evaluate the prevalence and risk factors of group B streptococcus (GBS)
colonization among pregnant women and their neonates in Greece, and to examine the …

Group B Streptococcus (GBS) remains the leading cause of neonatal sepsis and meningitis
in the United States, despite a dramatic 80% decline in the incidence of early-onset GBS …

Abstract Background Group B streptococcus (GBS) infection is a leading cause of severe
neonatal infection. Maternal GBS carriage during pregnancy is the main risk factor for both …

From 1993 through 1996, surveillance for invasive disease due to group B Streptococcus
(GBS) in neonates aged< 7 days and in peripartum pregnant women was performed in a …

Background Maternal recto-vaginal colonization with Group B Streptococcus (GBS) and
consequent vertical transmission to the newborn predisposes neonates to early-onset …

We aimed to define the burden and clinical features of invasive group B streptococcus (GBS)
disease in infants younger than 1 year in Japan, to explore transmission route of late-onset …